Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical study of patients with poor ovarian response and premature ovarian insufficiency
ChiCTR-IPR-17010945Phase 4Recruiting
- Sponsor
- Peking University Third Hospital
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of coenzyme q10, DehydraTECH-estrogen and progesterone in poor ovarian response (POR) and ovarian hypofunction (POI) (2 arms), sponsored by Peking University Third Hospital. Primary endpoints: clinical pregnancy rate, abortion rate and 3 more. Started Jun 2015; status: recruiting.
02
Drugs
coenzyme q10DehydraTECH-estrogenprogesterone
03
Conditions
poor ovarian response (POR)ovarian hypofunction (POI)
Beyond the preview
Go deeper on ChiCTR-IPR-17010945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17010945.